Ann: Response to ASX Appendix 3Y Query, page-13

Andylo,

I support you on your post which unfortunately was moderated. But your concern that David Breeze will sink the company and then pick up the assets for a song is certainly a worry to many shareholders like myself. It has been happened in other companies.

I am very much encouraged by the possible class action law suit taken by shareholders against Bellamy's recently by Maurice Blackburn. ACA Lawyers and Slater & Gordon is also considering a second class action law suit against the Bellamy's board. Pls refer to: https://www.mauriceblackburn.com.au/current-class-actions/bellamy-s-class-action/

Scrutinizing the annual report of BPH, the company owes more than $1.15M to a few directors with the bulk ($700K) owed to David Breeze. The company has less than $600K of cash. David can send the company into insolvency should his Chairman position be threatened. Is he thus doing the right issues to pay himself and his directors first as there was no mention of the proceed of fund usage? Can the company board explain to shareholders what they they did over the last two years that adds value to the company? None of the board members including Breeze has any medical science experiences, commercialised a device or even sell a health product. Why do shareholders owed them anything?

David Breeze has never answered to shareholders on this forum or answer calls to his office. He called selected important shareholders when he want them to listen to his "allegation of wrong doings by others".

Shareholders like myself are angry being unfairly diluted by this rights issue and the loss of stock value. Time to get angry and act. Time to start talking to Messr Maurice Blackburn and others from being rip off.

A reminder to other shareholders: the "David Breeze effect". Pls think before you vote!